Vaccine Adjuvants Market Report

Europe Vaccine Adjuvants Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 12, 2019
  • PAGES：181
  • REPORT CODE：GMM315532
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Vaccine Adjuvants market was valued at 652 Million US$ in 2018 and is projected to reach 1459 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Vaccine Adjuvants Market Segmentations:

    By Player:

    • InvivoGen

    • GlaxoSmithKline

    • Oz Biosciences

    • Vaxine Pty Ltd

    • OZ Biosciences.

    • Novavax

    • Adjuvance

    • SPI Pharma

    • Vaxliant

    • SEPPIC

    • CureVac AG

    • Merck KGaA

    • Brenntag AG

    • Chemtrade Logistics

    • Aphios

    • Seppic

    By Type:

    • Mineral Salt Based Adjuvants

    • Tensoactive Adjuvants

    • Emulsions

    • Liposomes

    • Carbohydrates Adjuvants

    • Bacteria-Derived Adjuvants

    • Organic Adjuvants

    • Virus-Like Particles

    • Others

    By End-User:

    • Infectious Disease

    • Therapeutic

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Vaccine Adjuvants Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Vaccine Adjuvants Market Size and Growth Rate of Mineral Salt Based Adjuvants from 2014 to 2026

    • 1.3.2 Europe Vaccine Adjuvants Market Size and Growth Rate of Tensoactive Adjuvants from 2014 to 2026

    • 1.3.3 Europe Vaccine Adjuvants Market Size and Growth Rate of Emulsions from 2014 to 2026

    • 1.3.4 Europe Vaccine Adjuvants Market Size and Growth Rate of Liposomes from 2014 to 2026

    • 1.3.5 Europe Vaccine Adjuvants Market Size and Growth Rate of Carbohydrates Adjuvants from 2014 to 2026

    • 1.3.6 Europe Vaccine Adjuvants Market Size and Growth Rate of Bacteria-Derived Adjuvants from 2014 to 2026

    • 1.3.7 Europe Vaccine Adjuvants Market Size and Growth Rate of Organic Adjuvants from 2014 to 2026

    • 1.3.8 Europe Vaccine Adjuvants Market Size and Growth Rate of Virus-Like Particles from 2014 to 2026

    • 1.3.9 Europe Vaccine Adjuvants Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Vaccine Adjuvants Market Size and Growth Rate of Infectious Disease from 2014 to 2026

    • 1.4.2 Europe Vaccine Adjuvants Market Size and Growth Rate of Therapeutic from 2014 to 2026

    • 1.4.3 Europe Vaccine Adjuvants Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Vaccine Adjuvants Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Vaccine Adjuvants by Major Types

      • 3.4.1 Market Size and Growth Rate of Mineral Salt Based Adjuvants

      • 3.4.2 Market Size and Growth Rate of Tensoactive Adjuvants

      • 3.4.3 Market Size and Growth Rate of Emulsions

      • 3.4.4 Market Size and Growth Rate of Liposomes

      • 3.4.5 Market Size and Growth Rate of Carbohydrates Adjuvants

      • 3.4.6 Market Size and Growth Rate of Bacteria-Derived Adjuvants

      • 3.4.7 Market Size and Growth Rate of Organic Adjuvants

      • 3.4.8 Market Size and Growth Rate of Virus-Like Particles

      • 3.4.9 Market Size and Growth Rate of Others

    4 Segmentation of Vaccine Adjuvants Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Vaccine Adjuvants by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Vaccine Adjuvants for Infectious Disease

      • 4.4.2 Market Size and Growth Rate of Vaccine Adjuvants for Therapeutic

      • 4.4.3 Market Size and Growth Rate of Vaccine Adjuvants for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Vaccine Adjuvants Production Analysis by Top Regions

    • 5.2 Europe Vaccine Adjuvants Consumption Analysis by Top Regions

    • 5.3 Europe Vaccine Adjuvants Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Vaccine Adjuvants Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Vaccine Adjuvants Production, Import, Consumption and Export Analysis

      • 5.3.3 France Vaccine Adjuvants Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Vaccine Adjuvants Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Vaccine Adjuvants Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Vaccine Adjuvants Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Vaccine Adjuvants Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Vaccine Adjuvants Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Vaccine Adjuvants Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    6 Product Circulation of Vaccine Adjuvants Market among Top Countries

    • 6.1 Top 5 Export Countries in Vaccine Adjuvants Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Vaccine Adjuvants Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Vaccine Adjuvants Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Vaccine Adjuvants Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Vaccine Adjuvants Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Vaccine Adjuvants Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Vaccine Adjuvants Landscape Analysis

    • 7.1 Germany Vaccine Adjuvants Landscape Analysis by Major Types

    • 7.2 Germany Vaccine Adjuvants Landscape Analysis by Major End-Users

    8. UK Vaccine Adjuvants Landscape Analysis

    • 8.1 UK Vaccine Adjuvants Landscape Analysis by Major Types

    • 8.2 UK Vaccine Adjuvants Landscape Analysis by Major End-Users

    9. France Vaccine Adjuvants Landscape Analysis

    • 9.1 France Vaccine Adjuvants Landscape Analysis by Major Types

    • 9.2 France Vaccine Adjuvants Landscape Analysis by Major End-Users

    10. Italy Vaccine Adjuvants Landscape Analysis

    • 10.1 Italy Vaccine Adjuvants Landscape Analysis by Major Types

    • 10.2 Italy Vaccine Adjuvants Landscape Analysis by Major End-Users

    11. Spain Vaccine Adjuvants Landscape Analysis

    • 11.1 Spain Vaccine Adjuvants Landscape Analysis by Major Types

    • 11.2 Spain Vaccine Adjuvants Landscape Analysis by Major End-Users

    12. Poland Vaccine Adjuvants Landscape Analysis

    • 12.1 Poland Vaccine Adjuvants Landscape Analysis by Major Types

    • 12.2 Poland Vaccine Adjuvants Landscape Analysis by Major End-Users

    13. Russia Vaccine Adjuvants Landscape Analysis

    • 13.1 Russia Vaccine Adjuvants Landscape Analysis by Major Types

    • 13.2 Russia Vaccine Adjuvants Landscape Analysis by Major End-Users

    14. Switzerland Vaccine Adjuvants Landscape Analysis

    • 14.1 Switzerland Vaccine Adjuvants Landscape Analysis by Major Types

    • 14.2 Switzerland Vaccine Adjuvants Landscape Analysis by Major End-Users

    15. Turkey Vaccine Adjuvants Landscape Analysis

    • 15.1 Turkey Vaccine Adjuvants Landscape Analysis by Major Types

    • 15.2 Turkey Vaccine Adjuvants Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Landscape Analysis by Top Countries

      • 16.3.1 Denmark Vaccine Adjuvants Market Volume and Growth Rate

      • 16.3.2 Finland Vaccine Adjuvants Market Volume and Growth Rate

      • 16.3.3 Norway Vaccine Adjuvants Market Volume and Growth Rate

      • 16.3.4 Sweden Vaccine Adjuvants Market Volume and Growth Rate

      • 16.3.6 Iceland Vaccine Adjuvants Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Landscape Analysis by Top Countries

      • 17.3.1 Belgium Vaccine Adjuvants Market Volume and Growth Rate

      • 17.3.2 Netherlands Vaccine Adjuvants Market Volume and Growth Rate

      • 17.3.3 Luxembourg Vaccine Adjuvants Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Landscape Analysis by Top Countries

      • 18.3.1 Estonia Vaccine Adjuvants Market Volume and Growth Rate

      • 18.3.2 Latvia Vaccine Adjuvants Market Volume and Growth Rate

      • 18.3.3 Lithuania Vaccine Adjuvants Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 InvivoGen

      • 19.1.1 InvivoGen Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 GlaxoSmithKline

      • 19.2.1 GlaxoSmithKline Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Oz Biosciences

      • 19.3.1 Oz Biosciences Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Vaxine Pty Ltd

      • 19.4.1 Vaxine Pty Ltd Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 OZ Biosciences.

      • 19.5.1 OZ Biosciences. Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Novavax

      • 19.6.1 Novavax Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Adjuvance

      • 19.7.1 Adjuvance Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 SPI Pharma

      • 19.8.1 SPI Pharma Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Vaxliant

      • 19.9.1 Vaxliant Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 SEPPIC

      • 19.10.1 SEPPIC Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 CureVac AG

      • 19.11.1 CureVac AG Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Merck KGaA

      • 19.12.1 Merck KGaA Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Brenntag AG

      • 19.13.1 Brenntag AG Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Chemtrade Logistics

      • 19.14.1 Chemtrade Logistics Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Aphios

      • 19.15.1 Aphios Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Seppic

      • 19.16.1 Seppic Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    The List of Tables and Figures (Totals 66 Figures and 139 Tables)

    • Figure Product Picture

    • Figure Europe Vaccine Adjuvants Market Size and Growth Rate of Mineral Salt Based Adjuvants from 2014 to 2026

    • Figure Europe Vaccine Adjuvants Market Size and Growth Rate of Tensoactive Adjuvants from 2014 to 2026

    • Figure Europe Vaccine Adjuvants Market Size and Growth Rate of Emulsions from 2014 to 2026

    • Figure Europe Vaccine Adjuvants Market Size and Growth Rate of Liposomes from 2014 to 2026

    • Figure Europe Vaccine Adjuvants Market Size and Growth Rate of Carbohydrates Adjuvants from 2014 to 2026

    • Figure Europe Vaccine Adjuvants Market Size and Growth Rate of Bacteria-Derived Adjuvants from 2014 to 2026

    • Figure Europe Vaccine Adjuvants Market Size and Growth Rate of Organic Adjuvants from 2014 to 2026

    • Figure Europe Vaccine Adjuvants Market Size and Growth Rate of Virus-Like Particles from 2014 to 2026

    • Figure Europe Vaccine Adjuvants Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Vaccine Adjuvants Market Size and Growth Rate of Infectious Disease from 2014 to 2026

    • Figure Europe Vaccine Adjuvants Market Size and Growth Rate of Therapeutic from 2014 to 2026

    • Figure Europe Vaccine Adjuvants Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure UK Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure France Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Vaccine Adjuvants Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Vaccine Adjuvants

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Vaccine Adjuvants by Different Types from 2014 to 2026

    • Table Consumption Share of Vaccine Adjuvants by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Mineral Salt Based Adjuvants

    • Figure Market Size and Growth Rate of Tensoactive Adjuvants

    • Figure Market Size and Growth Rate of Emulsions

    • Figure Market Size and Growth Rate of Liposomes

    • Figure Market Size and Growth Rate of Carbohydrates Adjuvants

    • Figure Market Size and Growth Rate of Bacteria-Derived Adjuvants

    • Figure Market Size and Growth Rate of Organic Adjuvants

    • Figure Market Size and Growth Rate of Virus-Like Particles

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Vaccine Adjuvants by Different End-Users from 2014 to 2026

    • Table Consumption Share of Vaccine Adjuvants by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Infectious Disease

    • Figure Market Size and Growth Rate of Therapeutic

    • Figure Market Size and Growth Rate of Others

    • Table Europe Vaccine Adjuvants Production by Major Regions

    • Table Europe Vaccine Adjuvants Production Share by Major Regions

    • Figure Europe Vaccine Adjuvants Production Share by Major Countries and Regions in 2014

    • Table Europe Vaccine Adjuvants Consumption by Major Regions

    • Table Europe Vaccine Adjuvants Consumption Share by Major Regions

    • Table Germany Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • Table UK Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • Table France Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • Table Italy Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • Table Spain Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • Table Poland Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • Table Russia Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • Table Switzerland Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • Table Turkey Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Vaccine Adjuvants Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Vaccine Adjuvants Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Vaccine Adjuvants Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Vaccine Adjuvants Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Vaccine Adjuvants Consumption by Types from 2014 to 2026

    • Table Germany Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

    • Table Germany Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

    • Table Germany Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

    • Table UK Vaccine Adjuvants Consumption by Types from 2014 to 2026

    • Table UK Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

    • Table UK Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

    • Table UK Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

    • Table France Vaccine Adjuvants Consumption by Types from 2014 to 2026

    • Table France Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

    • Table France Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

    • Table France Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

    • Table Italy Vaccine Adjuvants Consumption by Types from 2014 to 2026

    • Table Italy Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

    • Table Italy Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

    • Table Italy Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

    • Table Spain Vaccine Adjuvants Consumption by Types from 2014 to 2026

    • Table Spain Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

    • Table Spain Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

    • Table Spain Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

    • Table Poland Vaccine Adjuvants Consumption by Types from 2014 to 2026

    • Table Poland Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

    • Table Poland Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

    • Table Poland Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

    • Table Russia Vaccine Adjuvants Consumption by Types from 2014 to 2026

    • Table Russia Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

    • Table Russia Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

    • Table Russia Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Vaccine Adjuvants Consumption by Types from 2014 to 2026

    • Table Switzerland Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

    • Table Switzerland Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

    • Table Switzerland Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Vaccine Adjuvants Consumption by Types from 2014 to 2026

    • Table Turkey Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

    • Table Turkey Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

    • Table Turkey Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Vaccine Adjuvants Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Vaccine Adjuvants Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Vaccine Adjuvants Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of InvivoGen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of InvivoGen

    • Figure Sales and Growth Rate Analysis of InvivoGen

    • Figure Revenue and Market Share Analysis of InvivoGen

    • Table Product and Service Introduction of InvivoGen

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Oz Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oz Biosciences

    • Figure Sales and Growth Rate Analysis of Oz Biosciences

    • Figure Revenue and Market Share Analysis of Oz Biosciences

    • Table Product and Service Introduction of Oz Biosciences

    • Table Company Profile and Development Status of Vaxine Pty Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vaxine Pty Ltd

    • Figure Sales and Growth Rate Analysis of Vaxine Pty Ltd

    • Figure Revenue and Market Share Analysis of Vaxine Pty Ltd

    • Table Product and Service Introduction of Vaxine Pty Ltd

    • Table Company Profile and Development Status of OZ Biosciences.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OZ Biosciences.

    • Figure Sales and Growth Rate Analysis of OZ Biosciences.

    • Figure Revenue and Market Share Analysis of OZ Biosciences.

    • Table Product and Service Introduction of OZ Biosciences.

    • Table Company Profile and Development Status of Novavax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novavax

    • Figure Sales and Growth Rate Analysis of Novavax

    • Figure Revenue and Market Share Analysis of Novavax

    • Table Product and Service Introduction of Novavax

    • Table Company Profile and Development Status of Adjuvance

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adjuvance

    • Figure Sales and Growth Rate Analysis of Adjuvance

    • Figure Revenue and Market Share Analysis of Adjuvance

    • Table Product and Service Introduction of Adjuvance

    • Table Company Profile and Development Status of SPI Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SPI Pharma

    • Figure Sales and Growth Rate Analysis of SPI Pharma

    • Figure Revenue and Market Share Analysis of SPI Pharma

    • Table Product and Service Introduction of SPI Pharma

    • Table Company Profile and Development Status of Vaxliant

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vaxliant

    • Figure Sales and Growth Rate Analysis of Vaxliant

    • Figure Revenue and Market Share Analysis of Vaxliant

    • Table Product and Service Introduction of Vaxliant

    • Table Company Profile and Development Status of SEPPIC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SEPPIC

    • Figure Sales and Growth Rate Analysis of SEPPIC

    • Figure Revenue and Market Share Analysis of SEPPIC

    • Table Product and Service Introduction of SEPPIC

    • Table Company Profile and Development Status of CureVac AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CureVac AG

    • Figure Sales and Growth Rate Analysis of CureVac AG

    • Figure Revenue and Market Share Analysis of CureVac AG

    • Table Product and Service Introduction of CureVac AG

    • Table Company Profile and Development Status of Merck KGaA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA

    • Figure Sales and Growth Rate Analysis of Merck KGaA

    • Figure Revenue and Market Share Analysis of Merck KGaA

    • Table Product and Service Introduction of Merck KGaA

    • Table Company Profile and Development Status of Brenntag AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Brenntag AG

    • Figure Sales and Growth Rate Analysis of Brenntag AG

    • Figure Revenue and Market Share Analysis of Brenntag AG

    • Table Product and Service Introduction of Brenntag AG

    • Table Company Profile and Development Status of Chemtrade Logistics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chemtrade Logistics

    • Figure Sales and Growth Rate Analysis of Chemtrade Logistics

    • Figure Revenue and Market Share Analysis of Chemtrade Logistics

    • Table Product and Service Introduction of Chemtrade Logistics

    • Table Company Profile and Development Status of Aphios

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aphios

    • Figure Sales and Growth Rate Analysis of Aphios

    • Figure Revenue and Market Share Analysis of Aphios

    • Table Product and Service Introduction of Aphios

    • Table Company Profile and Development Status of Seppic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seppic

    • Figure Sales and Growth Rate Analysis of Seppic

    • Figure Revenue and Market Share Analysis of Seppic

    • Table Product and Service Introduction of Seppic

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US